Zosano Pharma Corporation (ZSAN) Stock Analyst Ratings
NASDAQ:ZSAN - Nasdaq - US98979H3012 - Common Stock
ChartMill assigns a Buy % Consensus number of 46% to ZSAN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.42. This target is 3741.46% above the current price.
ZSAN was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ZSAN.
In the last month the buy percentage fell by 34 points. So the trust of analysts is decreasing.
ZSAN was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-02-23 | BTIG | Downgrade | Buy -> Neutral |
| 2021-03-15 | Maxim Group | Maintains | Buy |